Explore GMP Excellence and Clinical Innovation with Ab Initio at ARCS 2025
Ab Initio Pharma is proud to be sponsoring and exhibiting at the ARCS 2025 Annual Conference, taking place in Sydney from 3–5 June 2025.
As a leading Australian Contract Development and Manufacturing Organisation (CDMO), we’re excited to showcase how our GMP-certified capabilities and scientific expertise support clients from early development through to clinical trials.
Join us at our exhibition booth to learn more about how we accelerate pharmaceutical development across a broad range of dosage forms, including:
Oral – capsules, and complex multiparticulates
Topical – creams, ointments, gels, and lipid-based systems
Inhalation – pMDIs, DPIs, and soft mist inhalers
Nasal – sprays and powders
From formulation and analytical development to clinical packaging and regulatory support, Ab Initio offers a seamless path to clinic-ready products.
We invite all ARCS delegates to visit us, meet our expert team, and explore how we can help bring your next product to life with speed, quality, and precision.
See you at ARCS 2025 in Sydney!
